BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33252908)

  • 1. Parkinson Disease.
    Halli-Tierney AD; Luker J; Carroll DG
    Am Fam Physician; 2020 Dec; 102(11):679-691. PubMed ID: 33252908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Treatment of Parkinson Disease: A Review.
    Armstrong MJ; Okun MS
    JAMA; 2020 Feb; 323(6):548-560. PubMed ID: 32044947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of Parkinson's disease].
    Baumann CR; Waldvogel D
    Praxis (Bern 1994); 2013 Dec; 102(25):1529-35. PubMed ID: 24326048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson disease: an update.
    Gazewood JD; Richards DR; Clebak K
    Am Fam Physician; 2013 Feb; 87(4):267-73. PubMed ID: 23418798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's Disease.
    Reich SG; Savitt JM
    Med Clin North Am; 2019 Mar; 103(2):337-350. PubMed ID: 30704685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the diagnosis and treatment of Parkinson disease.
    Rizek P; Kumar N; Jog MS
    CMAJ; 2016 Nov; 188(16):1157-1165. PubMed ID: 27221269
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinson's disease: making the diagnosis, selecting drug therapies.
    Scharre DW; Mahler ME
    Geriatrics; 1994 Oct; 49(10):14-6, 20-3. PubMed ID: 7926845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and emerging treatments for Parkinson disease.
    Fung VS
    Med J Aust; 2015 Apr; 202(6):283-4. PubMed ID: 25832138
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for Parkinson's disease.
    Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to the patient with Parkinson disease.
    Johnson KE
    Prim Care; 2015 Jun; 42(2):205-15. PubMed ID: 25979582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).
    Stocchi F; Marconi S
    Clin Neuropharmacol; 2010 Jul; 33(4):198-203. PubMed ID: 20414107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor fluctuations in Parkinson's disease.
    Weiner WJ
    Rev Neurol Dis; 2006; 3(3):101-8. PubMed ID: 17047575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatment of Parkinson disease: a review.
    Connolly BS; Lang AE
    JAMA; 2014 Apr 23-30; 311(16):1670-83. PubMed ID: 24756517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: therapeutic choices and timing decisions in patient management. Interview by Wayne Kuznar.
    Stacy M
    Geriatrics; 1999 Oct; 54(10):44-9; quiz 50. PubMed ID: 10542860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic considerations for the use of levodopa in the treatment of Parkinson disease: focus on levodopa/carbidopa/entacapone for treatment of levodopa-associated motor complications.
    Müller T
    Clin Neuropharmacol; 2013; 36(3):84-91. PubMed ID: 23673910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies.
    Pahwa R
    J Am Med Dir Assoc; 2006 Sep; 7(7 Suppl 2):4-10. PubMed ID: 17948613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States.
    Amjad F; Bhatti D; Davis TL; Oguh O; Pahwa R; Kukreja P; Zamudio J; Metman LV
    Adv Ther; 2019 Sep; 36(9):2233-2246. PubMed ID: 31278691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When the going gets tough: how to select patients with Parkinson's disease for advanced therapies.
    Worth PF
    Pract Neurol; 2013 Jun; 13(3):140-52. PubMed ID: 23487815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W; Schulz JB
    J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation-Refractory Symptoms in Advanced Parkinson Disease.
    Regidor I; Benita V; Del Álamo de Pedro M; Ley L; Martinez Castrillo JC
    Clin Neuropharmacol; 2017; 40(3):103-107. PubMed ID: 28452905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.